Tuesday morning at NHIA 2025 featured a breakfast symposium covering the clinical management of adverse reactions in immunoglobulin therapy, and our innovative 30-30-30 sessions that cover a central topic from 3 angles with unique perspectives. For example, IV workflow systems were examined from history of their development and use in hospital systems, to their current adoption in home infusion practice, and how to implement such a system if your organization chooses to operationalize one.

Monday morning kicked off with a high-octane networking breakfast before the General Session. We were fortunate to hear from Dr. Mark McClellan, who was FDA Commissioner and CMS Administrator under the George W. Bush administration, who joined NHIA President and CEO Connie Sullivan for a fireside chat.

NHIA 2025 convened the largest gathering dedicated to the home and alternate site infusion industry in Washington, D.C., featuring the event’s most extensive Expo ever with 150 product and service suppliers supporting the industry, including 39 first-time exhibitors. The conference continued to see an increase in individuals investing to attend the conference and nearly 1,600 industry professionals attended the 5-day event.